Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.
Open Access
- 1 September 1982
- Vol. 37 (9) , 667-670
- https://doi.org/10.1136/thx.37.9.667
Abstract
In patients with radiological evidence of pulmonary emphysema the bronchodilator drugs fenoterol and ipratropium bromide produced a considerable increase in vital capacity and reduction in residual volume. The response to fenoterol was virtually complete 15 minutes after administration, but after ipratropium bromide vital capacity was still increasing at 60 minutes. The change in vital capacity was slightly greater with a combination of the two drugs than with either used alone. Changes in FEV1 and peak flow rate were small.This publication has 9 references indexed in Scilit:
- Lung FunctionPublished by Wiley ,2006
- The effects of salbutamol aerosol on lung function in patients with pulmonary emphysemaRespiratory Medicine, 1981
- Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by InhalationAustralian and New Zealand Journal of Medicine, 1979
- Assessment of a combination of doses of fenoterol and ipratropium suitable for a single metered-dose aerosolEuropean Journal of Clinical Pharmacology, 1979
- Bronchodilatation and the site of airway resistance in severe chronic bronchitis.Thorax, 1979
- Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitisRespiratory Medicine, 1978
- Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.BMJ, 1975
- Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic BronchitisBMJ, 1973
- Emphysema and the Chest Film: A Retrospective Radiological and Pathological StudyThe British Journal of Radiology, 1962